The Case for the Development of a Chagas Disease Vaccine: Why? How? When?
- PMID: 33530605
- PMCID: PMC7851737
- DOI: 10.3390/tropicalmed6010016
The Case for the Development of a Chagas Disease Vaccine: Why? How? When?
Abstract
Chagas disease is a major neglected tropical disease, transmitted predominantly by triatomine insect vectors, but also through congenital and oral routes. While endemic in the Americas, it has turned into a global disease. Because of the current drug treatment limitations, a vaccine would represent a major advancement for better control of the disease. Here, we review some of the rationale, advances, and challenges for the ongoing development of a vaccine against Chagas disease. Recent pre-clinical studies in murine models have further expanded (i) the range of vaccine platforms and formulations tested; (ii) our understanding of the immune correlates for protection; and (iii) the extent of vaccine effects on cardiac function, beyond survival and parasite burden. We further discuss outstanding issues and opportunities to move Chagas disease development forward in the near future.
Keywords: Trypanosoma cruzi; Trypanosomiasis; neglected tropical disease; parasite.
Conflict of interest statement
The authors have no conflict of interest.
Similar articles
-
What makes an effective Chagas disease vector? Factors underlying Trypanosoma cruzi-triatomine interactions.Acta Trop. 2018 Jul;183:23-31. doi: 10.1016/j.actatropica.2018.04.008. Epub 2018 Apr 3. Acta Trop. 2018. PMID: 29625091 Review.
-
Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.Expert Rev Vaccines. 2015 May;14(5):681-97. doi: 10.1586/14760584.2015.989989. Epub 2014 Dec 11. Expert Rev Vaccines. 2015. PMID: 25496192 Review.
-
Chagas disease vaccine design: the search for an efficient Trypanosoma cruzi immune-mediated control.Biochim Biophys Acta Mol Basis Dis. 2020 May 1;1866(5):165658. doi: 10.1016/j.bbadis.2019.165658. Epub 2020 Jan 3. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 31904415 Review.
-
Trypanosoma cruzi Infection Prevalence and Bloodmeal Analysis in Triatomine Vectors of Chagas Disease From Rural Peridomestic Locations in Texas, 2013-2014.J Med Entomol. 2016 Jul;53(4):911-918. doi: 10.1093/jme/tjw040. Epub 2016 Apr 22. J Med Entomol. 2016. PMID: 27106934
-
Spatial distribution of triatomine bugs in a Chagas disease endemic region in Brazil.Rev Soc Bras Med Trop. 2019 Nov 14;52:e20190278. doi: 10.1590/0037-8682-0278-2019. eCollection 2019. Rev Soc Bras Med Trop. 2019. PMID: 31778421
Cited by
-
Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease.J Immunol Res. 2022 Aug 17;2022:5230603. doi: 10.1155/2022/5230603. eCollection 2022. J Immunol Res. 2022. PMID: 36033396 Free PMC article. Review.
-
Safety and preservation of cardiac function following therapeutic vaccination against Trypanosoma cruzi in rhesus macaques.J Microbiol Immunol Infect. 2023 Apr;56(2):400-407. doi: 10.1016/j.jmii.2022.09.003. Epub 2022 Sep 29. J Microbiol Immunol Infect. 2023. PMID: 36210315 Free PMC article.
-
Control of myeloid-derived suppressor cell dynamics potentiates vaccine protection in multiple mouse models of Trypanosoma cruzi infection.Front Immunol. 2024 Nov 1;15:1484290. doi: 10.3389/fimmu.2024.1484290. eCollection 2024. Front Immunol. 2024. PMID: 39555082 Free PMC article.
-
Immunoglobin and T cell receptor repertoire changes induced by a prototype vaccine against Chagas disease in naïve rhesus macaques.Res Sq [Preprint]. 2023 Nov 2:rs.3.rs-3453582. doi: 10.21203/rs.3.rs-3453582/v1. Res Sq. 2023. Update in: J Biomed Sci. 2024 Jun 1;31(1):58. doi: 10.1186/s12929-024-01050-5. PMID: 37961272 Free PMC article. Updated. Preprint.
-
Protective Efficacy of the Epitope-Conjugated Antigen N-Tc52/TSkb20 in Mitigating Trypanosoma cruzi Infection through CD8+ T-Cells and IFNγ Responses.Vaccines (Basel). 2024 Jun 4;12(6):621. doi: 10.3390/vaccines12060621. Vaccines (Basel). 2024. PMID: 38932350 Free PMC article.
References
-
- WHO Chagas disease in Latin America: An epidemiological update based on 2010 estimates. Wkly. Epidemiol. Rec. 2015;90:33–43. - PubMed
-
- Arnal A., Waleckx E., Rico-Chavez O., Herrera C., Dumonteil E. Estimating the current burden of Chagas disease in Mexico: A systematic review and meta-analysis of epidemiological surveys from 2006 to 2017. PLoS Negl. Trop. Dis. 2019;13:e0006859. doi: 10.1371/journal.pntd.0006859. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources